Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011 · see citing works

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802 · see citing works

Multiple sclerosis

Compston, A., & Coles, A. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,459 · see citing works

New Multiple Sclerosis Phenotypic Classification

LUBLIN, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,277 · see citing works

Mechanisms of angiogenesis and arteriogenesis

Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,146 · see citing works

Vascular-specific growth factors and blood vessel formation

Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · see citing works

Chemokines and leukocyte traffic

Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,685 · see citing works

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Woude, G. F. V., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,226 · see citing works

Chemokines

Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,983 · see citing works

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E. E., Garren, H., Langer-Gould, A. M., Strober, S., Cannella, B., Allard, J. D., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,659 · see citing works

Chemokines and disease

Gerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357 · see citing works

Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis

Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J. A., Newcombe, J., Esiri, M. M., & Fugger, L. H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,180 · see citing works

VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment

Cursiefen, C., Chen, L., Borges, L. P., Jackson, D. G., Cao, J., Radziejewski, C. H., D'Amore, P. A., Dana, M. R., Wiegand, S. J., & Streilein, J. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20465 · Cited by 1,054 · see citing works

Clinical applications of angiogenic growth factors and their inhibitors

Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004 · see citing works

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

Sørensen, T. L., Tani, M., Jensen, J. S., Pierce, V., Lucchinetti, C. F., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F. T., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 994 · see citing works

CCR5 + and CXCR3 + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions

Balashov, K. E., Rottman, J. B., Weiner, H. L., & Hancock, W. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6873 · Cited by 848 · see citing works

Chemokines.

Rollins, B. J. (1997) · PubMed · Cited by 603 · see citing works

Mechanism of met oncogene activation

Park, M., Dean, M. C., Cooper, C. S., Schmidt, M. C., O’Brien, S. J., Blair, D. G., & Woude, G. F. V. (1986) · Cell · doi:10.1016/0092-8674(86)90564-7 · Cited by 555 · see citing works

Role and Therapeutic Potential of VEGF in the Nervous System

de Almodóvar, C. R., Lambrechts, D., Mazzone, M., & Carmeliet, P. (2009) · Physiological Reviews · doi:10.1152/physrev.00031.2008 · Cited by 443 · see citing works

Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions

Simpson, J. E., Newcombe, J., Cuzner, M. L., & Woodroofe, M. N. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00208-7 · Cited by 403 · see citing works

Chemokine expression in murine experimental allergic encephalomyelitis

Godiska, R., Chantry, D., Dietsch, G. N., & Gray, P. W. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00008-p · Cited by 347 · see citing works

Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4 + T cells via CD40 ligand

Balashov, K. E., Smith, D. R., Khoury, S. J., Hafler, D. A., & Weiner, H. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.599 · Cited by 316 · see citing works

The expression and function of chemokines involved in CNS inflammation

Ubogu, E. E., Cossoy, M. B., & Ransohoff, R. M. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.002 · Cited by 277 · see citing works

Interferon β decreases T cell activation and interferon γ production in multiple sclerosis

Noronha, A., Toscas, A., & Jensen, M. A. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90244-s · Cited by 260 · see citing works

Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult

Graumann, U., Reynolds, R., Steck, A. J., & Schaeren‐Wiemers, N. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00485.x · Cited by 231 · see citing works

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Lüer, W., & Poser, S. (1994) · Neurology · doi:10.1212/wnl.44.8.1523 · Cited by 223 · see citing works

Epidermal Growth Factor Induces the Progeny of Subventricular Zone Type B Cells to Migrate and Differentiate into Oligodendrocytes

González-Pérez, Ó., Romero-Rodriguez, R., Soriano‐Navarro, M., García‐Verdugo, J. M., & Álvarez-Buylla, A. (2009) · Stem Cells · doi:10.1002/stem.119 · Cited by 217 · see citing works

Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis

Hulkower, K. I., Brosnan, C. F., Aquino, D. A., Cammer, W., Kulshrestha, S., Guida, M. P., Rapoport, D. A., & Berman, J. W. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.6.2525 · Cited by 210 · see citing works

Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies

Szczuciński, A., & Losy, J. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00749.x · Cited by 205 · see citing works

Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor

Honda, S., Kagoshima, M., Wanaka, A., Tohyama, M., Matsumoto, K., & Nakamura, T. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00075-4 · Cited by 184 · see citing works

VEGF-mediated inflammation precedes angiogenesis in adult brain

Croll, S. D. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.02.010 · Cited by 184 · see citing works

Vascular Endothelial Growth Factor Is Expressed in Multiple Sclerosis Plaques and Can Induce Inflammatory Lesions in Experimental Allergic Encephalomyelitis Rats

Proescholdt, M. A., Jacobson, S., Tresser, N. J., Oldfield, E. H., & Merrill, M. J. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.10.914 · Cited by 180 · see citing works

Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain.

Jung, W., Ċastrén, E., Odenthal, M., Woude, G. F. V., Ishii, T., Dienes, H. P., Lindholm, D., & Schirmacher, P. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.2.485 · Cited by 180 · see citing works

Chemokines in autoimmune disease

Godessart, N., & Kunkel, S. L. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00277-1 · Cited by 154 · see citing works

Oligodendrocyte Progenitor Cells Derived from Human Embryonic Stem Cells Express Neurotrophic Factors

Zhang, Y. W., Denham, J., & Thies, R. S. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.943 · Cited by 147 · see citing works

The Chemokine System in Neuroinflammation: An Update

Ransohoff, R. M. (2002) · The Journal of Infectious Diseases · doi:10.1086/344266 · Cited by 145 · see citing works

The Immunology of Multiple Sclerosis and its Animal Model, Experimental Allergic Encephalomyelitis

Owens, T., & Sriram, S. (1995) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30061-6 · Cited by 142 · see citing works

Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis

Sørensen, T. L., Sellebjerg, F. T., Jensen, C. V., Strieter, R. M., & Ransohoff, R. M. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00327.x · Cited by 127 · see citing works

Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling

Misu, T., Onodera, H., Fujihara, K., Matsushima, K., Yoshie, O., Okita, N., Takase, S., & Itoyama, Y. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00456-2 · Cited by 125 · see citing works

Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells.

Adams, D., Harvath, L., Bottaro, D. P., Interrante, R., Catalano, G., Tanaka, Y., Strain, A. J., Hübscher, S. G., & Shaw, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7144 · Cited by 120 · see citing works

FGF-2 and Anosmin-1 Are Selectively Expressed in Different Types of Multiple Sclerosis Lesions

Clemente, D., Ortega, M. C., Arenzana, F. J., & de Castro, F. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1158-11.2011 · Cited by 119 · see citing works

CCL5 induces a pro-inflammatory profile in microglia in vitro

Škuljec, J., Sun, H., Pul, R., Bénardais, K., Ragancokova, D., Moharregh-Khiabani, D., Kotsiari, A., Trebst, C., & Stangel, M. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.05.001 · Cited by 118 · see citing works

Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis

Ibrahim, S. M. (2001) · Brain · doi:10.1093/brain/124.10.1927 · Cited by 116 · see citing works

Paracrine Regulation of Germinal Center B Cell Adhesion through the c-Met–Hepatocyte Growth Factor/Scatter Factor Pathway

van der Voort, R., Taher, T. E. I., Keehnen, R. M. J., Smit, L., Groenink, M., & Pals, S. T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2121 · Cited by 116 · see citing works

IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease

Scarpini, E. A., Galimberti, D., Baron, P., Clerici, R., Ronzoni, M., Conti, G. M., & Scarlato, G. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00680-3 · Cited by 110 · see citing works

TGF‐β‐treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF‐c‐Met pathway

Lalive, P. H., Paglinawan, R., Biollaz, G., Kappos, E. A., Leone, D. P., Malipiero, U., Relvas, J. B., Moransard, M., Suter, T. B., & Fontana, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200425430 · Cited by 110 · see citing works

Essential Contribution of Monocyte Chemoattractant Protein-1/C-C Chemokine Ligand-2 to Resolution and Repair Processes in Acute Bacterial Pneumonia

Amano, H., Morimoto, K., Senba, M., Wang, H., Ishida, Y., Kumatori, A., Yoshimine, H., Oishi, K., Mukaida, N., & Nagatake, T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.398 · Cited by 107 · see citing works

Review: Glial lineages and myelination in the central nervous system

Compston, A., Zajicek, J., Sussman, J. D., WEBB, A., Hall, G. L., MUIR, D., Shaw, C. E., Wood, A., & Scolding, N. J. (1997) · Journal of Anatomy · doi:10.1046/j.1469-7580.1997.19020161.x · Cited by 105 · see citing works

Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis

Hiehle, J. F., Lenkinski, R. E., Grossman, R. I., Dousset, V., Ramer, K., Schnall, M. D., Cohen, J. A., & González‐Scarano, F. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910320303 · Cited by 104 · see citing works

Hepatocyte growth factor reduces astrocytic scar formation and promotes axonal growth beyond glial scars after spinal cord injury

Jeong, S. R., Kwon, M. J., Lee, H. G., Joe, E. H., Lee, J. H., Kim, S., Suh‐Kim, H., & Kim, B. G. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.10.021 · Cited by 103 · see citing works

The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease

Bartosik-Psujek, H., & Stelmasiak, Z. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00951.x · Cited by 102 · see citing works

Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings

Su, J.-J., Osoegawa, M., Matsuoka, T., Minohara, M., Tanaka, M., Ishizu, T., Mihara, F., Taniwaki, T., & Kira, J. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.11.006 · Cited by 98 · see citing works

Expression of HGF and cMet in the developing and adult brain

Achim, C. L., Katyal, S. L., Wiley, C. A., Shiratori, M., Wang, G., Oshika, E., Petersen, B. E., Li, J., & Michalopoulos, G. K. (1997) · Developmental Brain Research · doi:10.1016/s0165-3806(97)00108-9 · Cited by 92 · see citing works

Increased release of interleukin-12p40 in MS

Fassbender, K. C., Ragoschke, A., Rossol, S., Schwartz, A., Mielke, O., Paulig, A., & Hennerici, M. G. (1998) · Neurology · doi:10.1212/wnl.51.3.753 · Cited by 89 · see citing works

Aberrant T cell migration toward RANTES and MIP-1alpha in patients with multiple sclerosis: Overexpression of chemokine receptor CCR5

Zang, Y. C. Q. (2000) · Brain · doi:10.1093/brain/123.9.1874 · Cited by 84 · see citing works

Involvement of β-chemokines in the development of inflammatory demyelination

Banisor, I., Leist, T. P., & Kálmán, B. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-7 · Cited by 82 · see citing works

Experimental Autoimmune Encephalomyelitis on the SJL Mouse: Effect of γδ T Cell Depletion on Chemokine and Chemokine Receptor Expression in the Central Nervous System

Rajan, A. J., Asensio, V. C., Campbell, I. L., & Brosnan, C. F. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2120 · Cited by 82 · see citing works

The HGF Receptor/Met Tyrosine Kinase Is a Key Regulator of Dendritic Cell Migration in Skin Immunity

Baek, J.-H., Birchmeier, C., Zenke, M., & Hieronymus, T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200729 · Cited by 79 · see citing works

Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation

Carmody, R. J., Hilliard, B. A., Maguschak, K. A., Chodosh, L. A., & Chen, Y. H. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00366-1 · Cited by 75 · see citing works

CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis

Narikawa, K., Misu, T., Fujihara, K., Nakashima, I., Sato, S., & Itoyama, Y. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.12.010 · Cited by 73 · see citing works

Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients

Sarchielli, P., Filippo, M. D., Ercolani, M. V., Chiasserini, D., Mattioni, A., Bonucci, M., Tenaglia, S., Eusebi, P., & Calabresi, P. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.02.040 · Cited by 65 · see citing works

IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: Implications for their possible immunopathogenic roles

Malmeström, C., Andersson, B. A., Haghighi, S., & Lycke, J. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.004 · Cited by 63 · see citing works

Multiple sclerosis: prospective analysis of TNF-α and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity

Spuler, S., Yousry, T. A., Scheller, A., Voltz, R., Holler, E., Hartmann, M., Wick, M. W., & Hohlfeld, R. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00020-3 · Cited by 62 · see citing works

Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo

Goddard, D. R., Berry, M., Kirvell, S. L., & Butt, A. M. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1025 · Cited by 60 · see citing works

The impact of c-met/scatter factor receptor on dendritic cell migration

Kurz, S. M., Diebold, S. S., Hieronymus, T., Gust, T. C., Bartůněk, P., Sachs, M., Birchmeier, W., & Zenke, M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7 · Cited by 58 · see citing works

Neuroprotective role of fibroblast growth factor‐2 in experimental autoimmune encephalomyelitis

Rottlaender, A., Villwock, H., Addicks, K., & Küerten, S. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03450.x · Cited by 58 · see citing works

Identification of new sensitive biomarkers for the in vivo response to interferon‐β treatment in multiple sclerosis using DNA‐array evaluation

Sellebjerg, F. T., Krakauer, M., Hesse, D., Ryder, L. P., Alsing, I., Jensen, P. E. H., Koch‐Henriksen, N., Svejgaard, A., & Sørensen, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02716.x · Cited by 58 · see citing works

Differential release of β-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis

Sindern, E., Niederkinkhaus, Y., Henschel, M., Ossege, L. M., Patzold, T., & Malin, J. P. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.104002088.x · Cited by 52 · see citing works

Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats

Adzemovic, M. Z., Öckinger, J., Zeitelhofer, M., Hochmeister, S., Beyeen, A. D., Paulson, A., Gillett, A., Hedreul, M. T., Covacu, R., Lassmann, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039794 · Cited by 52 · see citing works

Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo

Butt, A. M., & Dinsdale, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.007 · Cited by 46 · see citing works

Chemokine Upregulation Follows Cytokine Expression in Chronic Relapsing Experimental Autoimmune Encephalomyelitis

Glabinski, A. R., Bielecki, B., & Ransohoff, R. M. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01285.x · Cited by 44 · see citing works

The Expression of VEGF-A Is Down Regulated in Peripheral Blood Mononuclear Cells of Patients with Secondary Progressive Multiple Sclerosis

Iacobaeus, E., Amoudruz, P., Ström, M., Khademi, M., Brundin, L., Hillert, J. A., Kockum, I. S., Malmström, V., Olsson, T. P., Tham, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019138 · Cited by 43 · see citing works

Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients

Bartosik-Psujek, H., & Stelmasiak, Z. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0225-9 · Cited by 40 · see citing works

Enhancement of Chemokine Expression by Interferon Beta Therapy in Patients With Multiple Sclerosis

Cepok, S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.138 · Cited by 40 · see citing works

Hepatocyte growth factor in cerebrospinal fluid in neurologic disease

Tsuboi, Y., Kakimoto, K., Akatsu, H., Daikuhara, Y., & Yamada, T. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2002.01125.x · Cited by 36 · see citing works

Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis

Müller, A. M., Jun, E., Conlon, H., & Sadiq, S. A. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.06.008 · Cited by 34 · see citing works

Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis

Öckinger, J., Stridh, P., Beyeen, A. D., Lundmark, F., Seddighzadeh, M., Oturai, A. B., Sørensen, P. S., Lorentzen, Å. R., Celius, E. G., Leppä, V., et al. (2009) · Genes and Immunity · doi:10.1038/gene.2009.82 · Cited by 30 · see citing works

Cytokine and IL-12 receptor mRNA discriminate between different clinical subtypes in multiple sclerosis

van Boxel-Dezaire, A. H. H., Smits, M., Trigt-Hoff, S. C. J. V., Killestein, J., van Houwelingen, H. C., Polman, C. H., & Nagelkerken, L. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00398-8 · Cited by 29 · see citing works

Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosis

Iarlori, C., Reale, M., Luca, G. D., Iorio, A. D., Feliciani, C., Tulli, A., Conti, P., Gambi, D., & Lugaresi, A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00487-8 · Cited by 26 · see citing works

CONCENTRATIONS OF HEPATOCYTE GROWTH FACTOR IN CEREBROSPINAL FLUID UNDER NORMAL AND DIFFERENT PATHOLOGICAL CONDITIONS

Kern, M. A., Bamborschke, S., Nekić, M., Schubert, D., Rydin, C., Lindholm, D., & Schirmacher, P. (2001) · Cytokine · doi:10.1006/cyto.2001.0875 · Cited by 25 · see citing works

Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis

Scalabrino, G., Galimberti, D., Mutti, E., Scalabrini, D., Veber, D., Riz, M. A. D., Bamonti, F., Capello, E., Mancardi, G., & Scarpini, E. A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.073 · Cited by 21 · see citing works

The Role of Cytokines in Experimental Autoimmune Encephalomyelitis

Bettelli, E., & Nicholson, L. B. (2001) · Springer eBooks · doi:10.1007/978-94-010-0981-2_9 · Cited by 20 · see citing works

Inducible expression of FGF2 by a rat oligodendrocyte precursor cell line promotes CNS myelination in vitro

Magy, L., Mertens, C., Avellana‐Adalid, V., Keita, M., Lachapelle, F., Nait‐Oumesmar, B., Fontaine, B., & Evercooren, A. B. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.019 · Cited by 19 · see citing works

Coadministration of epidermal growth factor and growth hormone releasing peptide-6 improves clinical recovery in experimental autoimmune encephalitis

del Barco, D. G., Montero, E., Coro-Antich, R. M., Brown, E., Suárez-Alba, J., Lopez, L., Subirós, N., & Berlanga, J. (2011) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2011-0595 · Cited by 18 · see citing works

Upregulation of vascular growth factors in multiple sclerosis : correlation with MRI findings

蘇, 真. (2009) · Medical Entomology and Zoology · Cited by 17 · see citing works

Evaluation of Serum Levels of Chemokines during Interferon-β Treatment in Multiple Sclerosis Patients

Comini-Frota, E. R., Teixeira, A. L., Angelo, J. P. A., de Andrade, M. V. M., Brum, D. G., Kaimen-Maciel, D. R., Foss, N. T., & Donadi, E. A. (2011) · CNS Drugs · doi:10.2165/11595060-000000000-00000 · Cited by 15 · see citing works

Steroid Therapy Altered Serum Levels of CCL2 and CCL5 Chemokines in Multiple Sclerosis Patients during Relapse

Bartosik-Psujek, H., & Stelmasiak, Z. (2004) · European Neurology · doi:10.1159/000082164 · Cited by 13 · see citing works

An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians

Bugeja, M. J., Booth, D. R., Bennetts, B., Heard, R. N., Rubio, J. P., & Stewart, G. J. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-64 · Cited by 12 · see citing works

An investigation of polymorphisms in the 4q13.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians

Bugeja, M. J., Booth, D. R., Bennetts, B., Heard, R. N., & Stewart, G. J. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506070964 · Cited by 7 · see citing works

Paracrine regulation of germinal center B cell adhesion through the c-Met-hepatocyte growth factor/scatter factor pathway

van der Voort, R., Taher, T. E. I., Keehnen, R. M. J., Smit, C., Groenink, M., & Pals, S. T. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)85430-2 · Cited by 1 · see citing works

An emerging role for eotaxins in neurodegenerative disease

Huber, A. K., Giles, D. A., Segal, B. M., & Irani, D. N. (2018) · Clinical Immunology · doi:10.1016/j.clim.2016.09.010 · Cited by 133 · see citing works

Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

Dhaiban, S., Al‐Ani, M., Elemam, N. M., & Maghazachi, A. A. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s270872 · Cited by 75 · see citing works

Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis

Morris, G., Reiche, E. M. V., Murru, A., Carvalho, A. F., Maes, M. H. J., Berk, M., & Puri, B. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0843-5 · Cited by 74 · see citing works

Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes

Arellano, G., Acuña, E., Reyes, L. I., Ottum, P. A., Sarno, P. D., Villarroel, L. A., Ciampi, E., Martín, R. U., Cárcamo, C., & Naves, R. F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00753 · Cited by 68 · see citing works

Senescent-like microglia limit remyelination through the senescence associated secretory phenotype

Gross, P. S., Durán-Laforet, V., Ho, L. T., Melchor, G. S., Zia, S., Manavi, Z., Barclay, W. E., Lee, S. H., Shults, N., Selva, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57632-w · Cited by 62 · see citing works

Epidermal Growth Factor in the CNS: A Beguiling Journey from Integrated Cell Biology to Multiple Sclerosis. An Extensive Translational Overview

Scalabrino, G. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00989-x · Cited by 48 · see citing works

A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis

Ghafouri‐Fard, S., Tamizkar, K. H., & Taheri, M. N. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00648-6 · Cited by 44 · see citing works

Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing–Remitting-Multiple Sclerosis Patients

D’Angelo, C., Reale, M., Costantini, E., Nicola, M. D., Porfilio, I., de Andrés, C., Fernández-Paredes, L., Sánchez‐Ramón, S., & Pasquali, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01240 · Cited by 35 · see citing works

Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF

Nicoletti, F., Mazzon, E., Fagone, P., Mangano, K., Mammana, S., Cavalli, E., Basile, M. S., Bramanti, P., Scalabrino, G., Lange, A., et al. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.05.006 · Cited by 33 · see citing works

Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-αand IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients

Lomakin, Y. A., Belogurov, A. A., Глаголева, И. С., Stepanov, A. V., Анатольевич, З. К., Okunola, J., Smirnov, I. V., Genkin, D. D., & Gabibov, A. G. (2016) · Mediators of Inflammation · doi:10.1155/2016/2847232 · Cited by 32 · see citing works

Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers

Ferrazzano, G., Crisafulli, S. G., Baione, V., Tartaglia, M., Cortese, A., Frontoni, M., Altieri, M., Pauri, F., Millefiorini, E., & Conte, A. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09964-4 · Cited by 31 · see citing works

SLAMF7 modulates B cells and adaptive immunity to regulate susceptibility to CNS autoimmunity

O’Connell, P. M., Blake, M. K., Godbehere, S., Amalfitano, A., & Aldhamen, Y. A. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02594-9 · Cited by 27 · see citing works

CCL26 and CCR3 are associated with the acute inflammatory response in the CNS in experimental autoimmune encephalomyelitis

Shou, J., Peng, J., Zhao, Z., Huang, X., Li, H., Li, L., Gao, X., Xing, Y., & Liu, H. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.576967 · Cited by 26 · see citing works

CCL11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-psychiatric DisordersPreprint

Ivanovska, M., Abdi, Z., Murdjeva, M., Macêdo, D. S., Maes, A., & Maes, M. H. J. (2020) · Preprints.org · doi:10.20944/preprints202001.0370.v1 · Cited by 24 · see citing works

Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer’s disease patients

Koca, S., Kiris, İ., Şahin, Ş., Çınar, N., Karşıdağ, S., Hanağası, H. A., Yıldız, G. B., & Baykal, A. T. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136799 · Cited by 23 · see citing works

Detection of Glycan Shedding in the Blood: New Class of Multiple Sclerosis Biomarkers?

DellaValle, B., Manresa-Arraut, A., Hasseldam, H., Stensballe, A., Rungby, J., Larsen, A., & Hempel, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01254 · Cited by 23 · see citing works

Lipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects

Fiedler, S. E., Yadav, V., Kerns, A. R., Tsang, C., Markwardt, S., Kim, E., Spain, R., BOURDETTE, D. N., & Salinthone, S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0813-y · Cited by 22 · see citing works

Elevated sCD40L in Secondary Progressive Multiple Sclerosis in Comparison to Non-progressive Benign and Relapsing Remitting Multiple Sclerosis

Wu, Q., Wang, Q., Yang, J., Martens, J. W. S., Mills, E. A., Saad, A., Chilukuri, P., Dowling, C. A., & Mao‐Draayer, Y. (2021) · Journal of Central Nervous System Disease · doi:10.1177/11795735211050712 · Cited by 21 · see citing works

Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

Kizlaitienė, R., Kaubrys, G., Giedraitienė, N., Ramanauskas, N., & Dementavičienė, J. (2017) · Medical Science Monitor · doi:10.12659/msm.903234 · Cited by 19 · see citing works

Emerging role of extracellular vesicles in multiple sclerosis: From cellular surrogates to pathogenic mediators and beyond

Palacio, P. L., Pleet, M. L., Reátegui, E., & Magaña, S. M. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578064 · Cited by 18 · see citing works

Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases

Ayoubi, N. K. E., & Khoury, S. J. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0486-7 · Cited by 17 · see citing works

The Effect of a Polysaccharide-Based Multinutrient Dietary Supplementation Regimen on Infections and Immune Functioning in Multiple Sclerosis

McDaniel, H. R., LaGanke, C. C., Bloom, L., Goldberg, S., Lages, L. C., Lantigua, L. A., Atlas, S. E., Woolger, J. M., & Lewis, J. E. (2018) · Journal of Dietary Supplements · doi:10.1080/19390211.2018.1495675 · Cited by 15 · see citing works

Increased cerebrospinal fluid levels of cytokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1β (MIP-1β) in patients with amyotrophic lateral sclerosis

Martínez, H. R., Escamilla-Ocañas, C. E., Camara-Lemarroy, C. R., González‐Garza, M. T., Moreno-Cuevas, J. E., & Sarreón, M. A. G. (2020) · Neurología (English Edition) · doi:10.1016/j.nrleng.2017.07.016 · Cited by 14 · see citing works

Multimarker risk stratification approach at multiple sclerosis onset

Fernández-Paredes, L., Casrouge, A., Decalf, J., de Andrés, C., Villar, L. M., de Diego, R. P., Alonso, B., Cermeño, J. C. Á., Arroyo, R., Tejera‐Alhambra, M., et al. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.05.019 · Cited by 13 · see citing works

Role of Cytokines, Chemokines and IFN-γ+ IL-17+ Double-Positive CD4+ T Cells in Patients with Multiple Sclerosis

de Sousa, M. A. D., Desidério, C. S., Catarino, J. D. S., Trevisan, R. O., da Silva, D. A. A., Rocha, V. F. R., Bovi, W. G., Timóteo, R. P., Bonatti, R. C. F., da Silva, A. E., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10092062 · Cited by 13 · see citing works

Development of an Electrochemical CCL5 Chemokine Immunoplatform for Rapid Diagnosis of Multiple Sclerosis

Guerrero, S., Sánchez‐Tirado, E., Agüı́, L., González-Cortés, A., Yáñez‐Sedeño, P., & Pingarrón, J. M. (2022) · Biosensors · doi:10.3390/bios12080610 · Cited by 12 · see citing works

New Epidermal-Growth-Factor-Related Insights Into the Pathogenesis of Multiple Sclerosis: Is It Also Epistemology?

Scalabrino, G. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.754270 · Cited by 12 · see citing works

Precision medicine for multiple sclerosis: an update of the available biomarkers and their use in therapeutic decision making

Valdeolivas, I. P., Zubizarreta, I., Martínez‐Lapiscina, E. H., & Villoslada, P. (2017) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2017.1393315 · Cited by 11 · see citing works

CCL11 (Eotaxin) Promotes the Advancement of Aging-Related Cardiovascular Diseases

Zhang, T., Huang, Y., Ji, X., Wu, T., & Xiao, P. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm26020 · Cited by 10 · see citing works

Multiplex array analysis of circulating cytokines and chemokines in natalizumab-treated patients with multiple sclerosis

Villani, S., Zanotta, N., Ambrogi, F., Comar, M., Franciotta, D. M., Dolci, M., Cason, C., Ticozzi, R., Ferrante, P., & Delbue, S. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.06.012 · Cited by 8 · see citing works

Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis

Bashamakh, L. F., Alsharif, S. M., Wayyani, L. A., Alghamdi, A., Fatani, G. M., Alnajashi, H. A., & Alshamrani, F. (2019) · Neurosciences · doi:10.17712/nsj.2019.4.20190027 · Cited by 8 · see citing works

Incremento de las citoquinas proteína quimiotáctica de monocitos-1 (MCP-1) y proteína inflamatoria macrofágica-1β (MIP-1β) en líquido cefalorraquídeo de pacientes con esclerosis lateral amiotrófica

Martínez, H. R., Escamilla-Ocañas, C. E., Camara-Lemarroy, C. R., González‐Garza, M. T., Moreno-Cuevas, J. E., & Sarreón, M. A. G. (2017) · Neurología · doi:10.1016/j.nrl.2017.07.020 · Cited by 8 · see citing works

High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes

Aso, Y., Iijima, T., Jojima, T., Saito, M., Tanuma, D., Kase, M., Sakurai, S., Tomaru, T., & Usui, I. (2024) · Postgraduate Medicine · doi:10.1080/00325481.2024.2347196 · Cited by 7 · see citing works

Peripheral blood age-sensitive immune markers in multiple sclerosis: relation to sex, cytomegalovirus status, and treatment

Desu, H. L., Balthazard, R., Daigneault, A., Cal, S. D., Klément, W., Yu, J. W., Clénet, M., Margarido, C., Levert, A., Fantodji, C., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105559 · Cited by 7 · see citing works

Novel Insights Into Gene Signatures and Their Correlation With Immune Infiltration of Peripheral Blood Mononuclear Cells in Behcet’s Disease

Zhan, H., Li, H., Cheng, L., Yan, S., Zheng, W., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.794800 · Cited by 7 · see citing works

Plasma Protein Levels Analysis in Multiple Sclerosis Sardinian Families Identified C9 and CYP24A1 as Candidate Biomarkers

Nova, A., Fazia, T., Beecham, A. H., Saddi, V., Piras, M., McCauley, J. L., Berzuini, C., & Bernardinelli, L. (2022) · Life · doi:10.3390/life12020151 · Cited by 5 · see citing works

Muscle Quality of Knee Extensors Based on Several Types of Force in Multiple Sclerosis Patients with Varying Degrees of Disability

Portilla-Cueto, K., Medina-Pérez, C., Romero-Pérez, E. M., Núñez-Othón, G., Horta-Gim, M. A., & Fernández, J. A. D. P. (2022) · Medicina · doi:10.3390/medicina58020316 · Cited by 5 · see citing works

Out with the old, in with the new: Could plasma exchange be used to fill a therapeutic gap in neurology?

Spencer, J. I., Crane, M., Pisa, M., Waldman, A. D., & DeLuca, G. C. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120056 · Cited by 5 · see citing works

BCL3, GBP1, IFI16, and CCR1 as potential brain-derived biomarkers for parietal grey matter lesions in multiple sclerosis

Guo, H., Li, Z., & Wang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-76949-y · Cited by 4 · see citing works

Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis

Peker, I., Icli, H. E., Mutluay, B., Yüksel, B., Özdemir, Z., Köseoğlu, M., Şen, A., Ataklı, D., Soysal, A., & Öztürk, M. (2024) · Biomedicines · doi:10.3390/biomedicines13010040 · Cited by 4 · see citing works

Serum HGF and APN2 are associated with disability worsening in SPMS

Tottenham, I., Koch, M. W., & Camara-Lemarroy, C. R. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577803 · Cited by 4 · see citing works

Human B-cells can form Hetero-aggregates with Blood Platelets: A Novel Insight into Adaptive Immunity Regulation in Multiple Sclerosis

Maciak, K., Dziedzic, A., Szymański, J., Studzian, M., Redlicka, J., Miller, E. D., Michlewska, S., Jóźwiak, P., & Saluk, J. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168885 · Cited by 3 · see citing works

Genetically Engineered Artificial Microvesicles Carrying Nerve Growth Factor Restrains the Progression of Autoimmune Encephalomyelitis in an Experimental Mouse Model

Alatrash, R., Golubenko, M., Martynova, E. V., Garanina, E. E., Mukhamedshina, Y. O., Khaiboullina, S. F., Rizvanov, A. A., Salafutdinov, I. I., & Arkhipova, S. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098332 · Cited by 3 · see citing works

Epidermal growth factor receptor modulation for neural repair: Implications for neurodegenerative disease therapy

Amin, A., & Badenes, M. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1891964 · Cited by 2 · see citing works

Multiple Sclerosis: Where Do We Go From Here?

Tejera‐Alhambra, M., Fernández-Paredes, L., de Andrés, C., & Sánchez‐Ramón, S. (2016) · EMJ Neurology · doi:10.33590/emjneurol/10313951 · Cited by 1 · see citing works

Effects of a potency and hypertrophy training programs on bone mineral density and mean power in people with multiple sclerosis for 7 weeks. A preliminary study

Montealegre, M. C., García, J. G., Pareja, M. T., Montealegre, C. C., & Láiz, N. M. (2020) · Cultura Ciencia y Deporte · doi:10.12800/ccd.v15i43.1394 · Cited by 1 · see citing works

Update on Promising Biomarkers for Multiple Sclerosis

Ahmad, F., Pathak, U., Das, A., & Dhar, A. (2021) · The Journal of Neurobehavioral Sciences · doi:10.4103/jnbs.jnbs_40_20 · Cited by 1 · see citing works

Comparación de los efectos producidos sobre la capacidad funcional, las manifestaciones de la fuerza y la calidad muscular del entrenamiento de fuerza clásico versus el reforzado excéntricamente en personas con esclerosis múltiple = Comparison of effects produced on functional capacity, strength manifestations and the muscle quality for classical resistance training versus eccentric-enhanced resistance training in people with multiple sclerosis

de Oliveira, C. E. P. (2018) · doi:10.18002/10612/7958

Pediatric Multiple Sclerosis: The role of magnetic resonance imaging and chemokine profile in the diagnosis and follow-up

Costa, A. A. P. E., Saad, T., Ignez, L. S., Gamarano, G. M. F., Lazzari, A. P., & de Vasconcelos, Z. F. M. (2018) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.64.08.672

Elucidating the functions of fibroblast growth factor 9 in multiple sclerosis

McElroy, D. (2018) · Enlighten: Theses (The University of Glasgow)

Dimethyl fumarate for treatment of multiple sclerosis : clinical effects and mechanisms

Granqvist, M. (2020) · Figshare

Immunopathology of multiple sclerosis

Tejera‐Alhambra, M., & Sánchez‐Ramón, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18578-6.00002-7

Angiogenesis biomarkers discriminate multiple sclerosis phenotypesPreprint

Yong, H. Y. F., Silva, C., Batty, N. J., Zhang, Y., Koch, M. W., & Camara-Lemarroy, C. R. (2024) · Research Square · doi:10.21203/rs.3.rs-4329965/v1

Additional file 2 of SLAMF7 modulates B cells and adaptive immunity to regulate susceptibility to CNS autoimmunity

O’Connell, P. M., Blake, M. K., Godbehere, S., Amalfitano, A., & Aldhamen, Y. A. (2022) · Figshare · doi:10.6084/m9.figshare.21285533

Additional file 1 of SLAMF7 modulates B cells and adaptive immunity to regulate susceptibility to CNS autoimmunity

O’Connell, P. M., Blake, M. K., Godbehere, S., Amalfitano, A., & Aldhamen, Y. A. (2022) · Figshare · doi:10.6084/m9.figshare.21285530

Reliable biomarkers for clinical forms of multiple sclerosis: development of personalized strategies based on IFN type I immnue signature.

Tejera‐Alhambra, M. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

Inflammation-related plasma and CSF biomarkers for multiple sclerosis

Huang, J., Khademi, M., Fugger, L., Lindhe, Ö., Novakova, L., Axelsson, M., Malmeström, C., Constantinescu, C., Lycke, J., Piehl, F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912839117 · Cited by 194 · see citing works

Reliable biomarkers for clinical forms of multiple sclerosis: development of personalized strategies based on IFN type I immnue signature.\nBiomarcadores de las formas clínicas de esclerosis múltiple: desarrollo de estrategias personalizadas basadas en perfiles inmunológicos de la vía del interferón de tipo I

Tejera‐Alhambra, M. (2013) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)

Plasma IgG aggregates as biomarkers for multiple sclerosis

Zhou, W., Graner, M. W., Beseler, C. L., Domashevich, T., Selva, S., Webster, G., Ledreux, A., Zizzo, Z., Lundt, M., Álvarez, E., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109801 · Cited by 11 · see citing works

Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients

Bai, Z., Chen, D., Wang, L., Zhao, Y. Q., Liu, T., Yu, Y., Yan, T., & Cheng, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01026 · Cited by 115 · see citing works